Temsamani Karim Saad
Known title: Chief Executive OfficerCIK: 0001944491
Associated companies
Transaction History
| CDLX | ▼ Sell | Open Market | 43,129 | $373K | 6/4/2024 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 84,079 | — | 6/1/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 32,564 | $446K | 4/2/2024 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 50,000 | — | 4/1/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 154 | $2K | 4/1/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 34,515 | $272K | 3/4/2024 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 84,078 | — | 3/1/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 31,123 | $242K | 1/3/2024 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 50,000 | — | 1/1/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 40,413 | $332K | 12/5/2023 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 84,079 | $0 | 12/1/2023 | View on chart |
| CDLX | ▼ Sell | Open Market | 15,463 | $210K | 10/2/2023 | View on chart |
| CDLX | ▼ Sell | Open Market | 8,299 | $124K | 10/2/2023 | View on chart |
| CDLX | ▼ Sell | Open Market | 4,708 | $74K | 10/2/2023 | View on chart |
| CDLX | ▼ Sell | Open Market | 106 | $2K | 10/2/2023 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 50,000 | — | 10/1/2023 | View on chart |
| CDLX | ▼ Sell | Open Market | 81,542 | $1.4M | 9/8/2023 | View on chart |
| CDLX | ▼ Sell | Open Market | 85,431 | $1.4M | 9/7/2023 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 336,315 | $0 | 9/1/2023 | View on chart |
| CDLX | ▼ Sell | Open Market | 25,574 | $157K | 7/3/2023 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 50,000 | $0 | 7/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CDLX: No company news in last 7 days
The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.
CDLX: No company news in last 7 days. The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.